Sonic Healthcare (OTCMKTS:SKHHY) is a global medical diagnostics provider headquartered in Sydney, Australia. The company specializes in comprehensive laboratory services, offering clinical pathology, anatomical pathology, molecular diagnostics and medicolegal testing. Through a focus on quality, innovation and rigorous accreditation standards, Sonic Healthcare supports hospitals, physicians and community healthcare providers with critical diagnostic and advisory services.
Founded in 1987, Sonic Healthcare has grown both organically and through strategic acquisitions to become one of the world’s leading diagnostics networks. It operates extensively in Australia and New Zealand, under the Sonic brand in the United States, and across Europe—including the United Kingdom, Germany and Switzerland—leveraging a shared platform for best practices, centralized quality control and advanced testing capabilities.
In addition to its pathology services, Sonic Healthcare’s diagnostic imaging division delivers a full spectrum of radiology procedures such as MRI, CT, ultrasound and interventional radiology. The company also invests in digital health solutions, telepathology platforms and precision medicine initiatives aimed at improving diagnostic turnaround times and accuracy. Its management team combines experienced healthcare executives and laboratory scientists committed to patient safety, regulatory compliance and continuous technological advancement.
AI Generated. May Contain Errors.
Free SKHHY Stock Alerts